BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cano CE, Pasero C, De Gassart A, Kerneur C, Gabriac M, Fullana M, Granarolo E, Hoet R, Scotet E, Rafia C, Herrmann T, Imbert C, Gorvel L, Vey N, Briantais A, le Floch AC, Olive D.
Cano CE, et al. Among authors: de gassart a.
Cell Rep. 2021 Jul 13;36(2):109359. doi: 10.1016/j.celrep.2021.109359.
Cell Rep. 2021.
PMID: 34260935
Free article.